Helicobacter pylori colonization leads to epithelial cell hyperproliferatio
n within inflamed mucosa, but levels of apoptosis vary, suggesting that imb
alances between rates of cell production and loss may contribute to differe
nces in gastric cancer risk among infected populations. Peroxisome prolifer
ator-activated receptor gamma (PPAR gamma) regulates inflammatory and growt
h responses of intestinal epithelial cells. We determined whether activatio
n of PPAR gamma modified H. pylori-induced apoptosis in gastric epithelial
cells. PPAR gamma was expressed and functionally active in gastric epitheli
al cell lines sensitive to H. pylori-induced apoptosis. PPAR gamma ligands
15d-PGJ(2) and BRL-49653 significantly attenuated H. pylori-induced apoptos
is, effects that could be reversed by co-treatment with a specific PPAR gam
ma antagonist., Cyclopentanone prostaglandins that do not bind and activate
PPAR gamma had no effects on H. pylori-induced apoptosis. The ability of H
. pylori to activate nuclear factor (NF)-kappaB and increase levels of the
NF-kappaB target IL-8 was blocked by co-treatment with PPAR gamma agonists,
and direct inhibition of NF-kappaB also abolished H. pylori-stimulated apo
ptosis. These results suggest that activation of the PPAR gamma pathway att
enuates the ability of H. pylori to induce NF-kappaB-mediated apoptosis in
gastric epithelial cells. Because PPAR gamma regulates a multitude of host
responses, activation of this receptor may contribute to varying levels of
cellular turnover as well as the diverse pathologic outcomes associated wit
h chronic H. pylori colonization.